BD (ticker: BDX), a leading global medical technology company, experienced a significant stock price drop of 5.01%. The share price fell to $228.04, with a trading volume of 1.86966 million shares and a turnover rate of 0.65%.
Recent financial reports indicate BD generated revenue of $4.99 billion, a net profit of $487 million, and earnings per share of $1.68. The company's gross profit stands at $2.307 billion, with a price-to-earnings ratio of 47.25.
In terms of analyst ratings, 85% of the 20 firms covering BD suggest a buy recommendation, while 15% recommend holding. Notably, no firms advise selling.
Within the broader medical equipment sector, where BD operates, the overall increase was 0.19%. Other notable stocks such as Innovative Eyewear Inc and Predictive Oncology Inc saw significant gains and activity in trading.
BD is renowned as one of the largest manufacturers and distributors of medical and surgical products, such as needles, syringes, and sharps management devices. The company's business segments include BD Medical, BD Life Sciences, and BD Interventional, which contribute to nearly half of its business volume. International sales account for 43% of BD's revenue.
